Insights

Expansion Potential Evofem recently expanded SOLOSEC into new markets by acquiring and relaunching the product and entering a distribution partnership to target sub-Saharan Africa, indicating growing global commercialization opportunities for BV and trichomoniasis treatments.

Strategic Partnerships The exclusive distribution agreement with Clovis Davis Pharmaceuticals to commercialize SOLOSEC in sub-Saharan Africa presents a clear channel for rapid market access and a blueprint for future regional alliances.

Product Portfolio Distinct two product lines PHEXXI and SOLOSEC address hormone-free contraception and single-dose BV/trichomoniasis therapy, offering cross-sell potential to healthcare providers focusing on women’s sexual and reproductive health.

Clinical Validation Recent data presentations and participation in major obstetric and gynecologic conferences (ACOG, Fierce JPM Week) support product efficacy and can be leveraged in provider education and payer discussions to drive adoption.

Cost Efficiency Reported manufacturing cost reduction for PHEXXI through a collaboration with Windtree Therapeutics suggests a path to improved margins and competitive pricing in negotiations with distributors, clinics, and health systems.

Evofem Biosciences Tech Stack

Evofem Biosciences uses 8 technology products and services including Matomo, Snowplow, WordPress, and more. Explore Evofem Biosciences's tech stack below.

Media & News

Evofem Biosciences's Email Address Formats

Evofem Biosciences uses at least 1 format(s):
Evofem Biosciences Email FormatsExamplePercentage
FLast@evofem.comJDoe@evofem.com
94%
Last@evofem.comDoe@evofem.com
4%
First@evofem.comJohn@evofem.com
1%
FirstL@evofem.comJohnD@evofem.com
1%

Frequently Asked Questions

What is Evofem Biosciences's phone number?

Minus sign iconPlus sign icon
You can contact Evofem Biosciences's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Evofem Biosciences's stock symbol?

Minus sign iconPlus sign icon
Evofem Biosciences is a publicly traded company; the company's stock symbol is EVFM.

What is Evofem Biosciences's official website and social media links?

Minus sign iconPlus sign icon
Evofem Biosciences's official website is evofem.com and has social profiles on LinkedIn.

How much revenue does Evofem Biosciences generate?

Minus sign iconPlus sign icon
As of August 2026, Evofem Biosciences's annual revenue is estimated to be $25M - $50M.

What is Evofem Biosciences's SIC code NAICS code?

Minus sign iconPlus sign icon
Evofem Biosciences's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Evofem Biosciences have currently?

Minus sign iconPlus sign icon
As of August 2026, Evofem Biosciences has approximately 39 employees across 2 continents, including North AmericaEurope. Key team members include Director, Medical Information: D. A.Senior Director, Supply Chain Logistics: J. A.Non Executive Director, Chair Compensation (remuneration) Committee, Member Of Audit Committee: T. O.. Explore Evofem Biosciences's employee directory with LeadIQ.

What industry does Evofem Biosciences belong to?

Minus sign iconPlus sign icon
Evofem Biosciences operates in the Pharmaceutical Manufacturing industry.

What technology does Evofem Biosciences use?

Minus sign iconPlus sign icon
Evofem Biosciences's tech stack includes MatomoSnowplowWordPressMicrosoft 365Constant ContactDocuSignWP EnginePiwik PRO Core.

What is Evofem Biosciences's email format?

Minus sign iconPlus sign icon
Evofem Biosciences's email format typically follows the pattern of FLast@evofem.com. Find more Evofem Biosciences email formats with LeadIQ.

When was Evofem Biosciences founded?

Minus sign iconPlus sign icon
Evofem Biosciences was founded in 2015.
Evofem Biosciences logo

Evofem Biosciences

Pharmaceutical ManufacturingCalifornia, United States11-50 Employees

Evofem Biosciences is a San Diego-based pharmaceutical company focused on sexual and reproductive health. It commercializes two FDA-approved products: a hormone-free, on-demand contraceptive vaginal gel launched in 2020, and SOLOSEC, a single-dose oral antibiotic approved for bacterial vaginosis and trichomoniasis, which Evofem acquired and relaunched in 2024. 

The company serves individuals seeking contraception and treatment for vaginal infections, with products used by healthcare providers in the women’s health space. It operates within the pharmaceutical manufacturing sector and is based in San Diego, California. A recent development in 2026 involves a five-year exclusive distributorship with Clovis Davis Pharmaceuticals to bring SOLOSEC to sub-Saharan Africa.

Section iconCompany Overview

Phone number
Website
evofem.com
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
EVFM
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2015
Employees
11-50

Section iconFunding & Financials

  • $25M - $50M

    Evofem Biosciences's revenue is estimated to be in the range of $25M - $50M

Section iconFunding & Financials

  • $25M - $50M

    Evofem Biosciences's revenue is estimated to be in the range of $25M - $50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.